Shehnaaz Suliman
Director/Board Member bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: 866 593 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Shehnaaz Suliman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 38 | |
| Public Company | Biotechnology | 20 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Biotechnology | 11 | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.
10
| Holding Company | Pharmaceuticals: Major | 10 |
| Public Company | Pharmaceuticals: Major | 7 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada.
1
| Private Company | Pharmaceuticals: Major | 1 |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Shehnaaz Suliman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| CELGENE | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Compliance Officer Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Public Communications Contact Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Founder | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Secretary Director/Board Member Director/Board Member | |
QuantaLife, Inc.
 QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member Founder Corporate Officer/Principal | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman Chairman | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
| University of California, Los Angeles | College/University | Graduate Degree Masters Business Admin Corporate Officer/Principal | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
| Georgia Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree Masters Business Admin | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member Chairman | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| DIMENSION THERAPEUTICS INC | Biotechnology | President Director/Board Member Treasurer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member Chairman Chief Executive Officer | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Chairman Investor Relations Contact | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Ierland | 3 |
| Zwitserland | 2 |
| Kaaimaneilanden | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 478 |
| Corporate Officer/Principal | 228 |
| Independent Dir/Board Member | 153 |
| Chairman | 73 |
| Undergraduate Degree | 71 |
Sterkste connecties
| Insiders | |
|---|---|
| Bryan Roberts | 44 |
| Paul Conley | 39 |
| Peter Thompson | 39 |
| Helen Kim | 33 |
| Henrietta Holsman Fore | 33 |
| Alan Colowick | 27 |
| Edward Hurwitz | 27 |
| Claudia Dyckerhoff | 26 |
| Daniel Welch | 24 |
| Daniel Zabrowski | 23 |
| Lars Ekman | 21 |
| Christine Pellizzari | 21 |
| Deborah Dunsire | 19 |
| Kim Popovits | 19 |
| Beatrice Weder di Mauro | 19 |
- Beurs
- Insiders
- Shehnaaz Suliman
- Bedrijfsconnecties
